India may issue warning against Marion's cough syrup exports

Published Date: 08 Mar 2023

India may issue a warning over cough syrup exported by Marion Biotech linked to a death in Uzbekistan.

Read Full News

Latest News

Would Earlier Initiation of Clozapine Improve FEP Outcomes?

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Hidden Bacteria Found in Common Kidney Stones

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Showing Future Heart Risks Visually Helps Patients Manage BP

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Cardiometabolic Control Elusive in Adults With Hypertension

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

Low eGFR Not Associated With DKA Risk in T1D

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Super-Resolution Ultrasound Can Track Early Kidney Disease

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Todays Updates

ctDNA-Guided Adjuvant Therapy Cuts Bladder Cancer Costs

Researchers evaluate whether postoperative ctDNA-guided adjuvant atezolizumab after radical cystectomy is cost-effective compared with standard care in patients with muscle-invasive bladder cancer.

PSA Often Unchanged With Enzalutamide Progression

A stable PSA level does not rule out progression in men taking enzalutamide for advanced prostate cancer.

Latest News

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

News All Time

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Young Adults With Glomerular Disease May Require Distinct Care

Young Adults With Glomerular Disease May Require Distinct Care

Q4 2025 Recap: Nephrology News and Updates

Q4 2025 Recap: Nephrology News and Updates

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

KDIGO Releases New Guideline for Anemia in Chronic Kidney Disease

KDIGO Releases New Guideline for Anemia in Chronic Kidney Disease

Recommended News For You

First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.

Nuclear missile workers are contracting cancer: They blame the bases

Researchers find distinct cell receptors with the potential for new treatments.

When it comes to LBCL relapse in complete remission, ASCT outperforms CAR T-cell therapy.

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

Colorectal Cancer Screening Uptake Tripled in 45-49 Age Group

More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer

Recommended Articles For You

A Breakthrough in Multiple Myeloma: Darzalex Delays Disease Progression by 51% 

Understanding Adenomyosis: The Role of Ultrasound in Diagnosis Introduction 

Tazemetostat: A Promising New Treatment for Cancer 

Screening Efficacy, Molecular Precision, and Therapeutic Revolutions in Lung Cancer 2025 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Belzutifan Combo Could be Second-Line Option in Advanced RCC

2.

FDA Approves Hemophilia B Second Gene Therapy.

3.

Experts Discuss Groundbreaking Advances in EGFR-Mutant Lung Cancer

4.

Study indicates that exercise can help colon cancer survivors live as long as matched individuals

5.

Study finds that AI is better at forecasting the risk of developing cancer.

1.

Understanding Macrocytosis: Causes, Symptoms, and Treatment Options 

2.

Navigating the Complexities of Esophageal Cancer Staging

3.

Unlocking the Secrets of Hemoglobin: Exploring the Wonders of Life-Sustaining Iron Compounds

4.

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer

5.

The Importance of Corrected Calcium Levels in Managing Health Conditions 

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

2.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V

3.

Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment

4.

A New Era in Managing Cancer-Associated Thrombosis

5.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part VII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot